Treatment failure of low molecular weight heparin bridging therapy in atrial fibrillation after acute coronary syndrome

Int J Cardiol. 2014 Feb 1;171(2):289-91. doi: 10.1016/j.ijcard.2013.11.079. Epub 2013 Dec 4.

Authors

E Imbalzano¹, R Ceravolo², R Di Stefano³, M Vatrano², A Saitta⁴

Affiliations

¹ Department of Internal Medicine, University of Messina, Italy. Electronic address: e.imbalzano@libero.it.
² Department of Cardiology, Hospital "Pugliese-Ciaccio" of Catanzaro, Italy.
³ Department of Surgical Pathology, Medical, Molecular and Critical Area, University of Pisa, Italy.
⁴ Department of Internal Medicine, University of Messina, Italy.

PMID: 24342410
DOI: 10.1016/j.ijcard.2013.11.079

No abstract available

Keywords: Atrial fibrillation; Ischemic stroke; Low-molecular-weight heparin; Oral anticoagulant therapy; Thrombosis prevention.

Publication types

Case Reports
Letter

MeSH terms

Acute Coronary Syndrome / complications*
Aged
Anticoagulants / adverse effects
Atrial Fibrillation / diagnosis
Atrial Fibrillation / drug therapy*
Atrial Fibrillation / etiology*
Brain Ischemia / diagnostic imaging
Brain Ischemia / prevention & control*
Heparin, Low-Molecular-Weight / adverse effects*
Humans
Intracranial Thrombosis / diagnostic imaging
Intracranial Thrombosis / prevention & control*
Male
Radiography
Treatment Failure

Substances

Anticoagulants
Heparin, Low-Molecular-Weight